Xiaobin Liu Selected Research

Creatinine

1/2024	Aggressive treatment may be needed for idiopathic membranous nephropathy with focal segmental glomerulosclerosis lesions.
6/2017	Evaluation of Serological Indicators and Glomerular Filtration Rate Equations in Chinese Cancer Patients.
1/2017	Ultrasensitive Quantitation of Anti-Phospholipase A2 Receptor Antibody as A Diagnostic and Prognostic Indicator of Idiopathic Membranous Nephropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaobin Liu Research Topics

Disease

23	Neoplasms (Cancer) 01/2024 - 11/2007
11	T-Cell Lymphoma (Lymphoma, T Cell) 12/2023 - 06/2006
10	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2024 - 01/2017
6	Lymphoma (Lymphomas) 01/2013 - 02/2008
5	Asthma (Bronchial Asthma) 01/2018 - 01/2017
4	Proteinuria 01/2024 - 01/2017
4	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2019 - 01/2016
4	Breast Neoplasms (Breast Cancer) 01/2019 - 11/2017
4	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 03/2014 - 02/2008
3	Burns 11/2023 - 01/2021
3	Wounds and Injuries (Trauma) 11/2023 - 01/2021
3	Kidney Diseases (Kidney Disease) 10/2022 - 10/2021
3	Lung Injury 02/2021 - 01/2019
3	Ischemia 01/2019 - 04/2015
3	Infections 01/2017 - 04/2015
2	Pneumonia (Pneumonitis) 04/2024 - 02/2021
2	Traumatic Brain Injuries (Traumatic Brain Injury) 04/2024 - 10/2012
2	Inflammation (Inflammations) 09/2023 - 11/2021
2	Carcinoma (Carcinomatosis) 11/2022 - 07/2022
2	Carcinogenesis 01/2022 - 06/2006
2	Acute Kidney Injury (Acute Renal Failure) 08/2021 - 01/2021
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2021 - 07/2015
2	Thrombosis (Thrombus) 01/2021 - 01/2006
2	Ventilator-Induced Lung Injury 11/2019 - 01/2019
2	Hypoglycemia (Reactive Hypoglycemia) 05/2017 - 08/2015
2	Hypoxia (Hypoxemia) 05/2017 - 08/2015
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2013 - 09/2005
2	Hyperglycemia 02/2012 - 07/2011
1	Cataract (Cataracts) 03/2024
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2024
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024

Drug/Important Bio-Agent (IBA)

8	Phospholipase A2 ReceptorsIBA 01/2024 - 01/2017
8	Phosphotransferases (Kinase)IBA 12/2023 - 02/2008
8	Anaplastic Lymphoma KinaseIBA 01/2022 - 06/2006
7	Proteins (Proteins, Gene)FDA Link 10/2023 - 12/2008
6	AntibodiesIBA 01/2024 - 08/2009
6	CytokinesIBA 02/2021 - 02/2008
5	OzoneIBA 01/2018 - 01/2017
4	EnzymesIBA 12/2023 - 01/2013
4	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 01/2013
4	Mechanistic Target of Rapamycin Complex 1IBA 12/2013 - 02/2008
3	Immunoglobulin G (IgG)IBA 01/2024 - 11/2019
3	CreatinineIBA 01/2024 - 01/2017
3	NucleophosminIBA 01/2022 - 04/2009
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022 - 11/2007
3	Oxygen (Dioxygen)IBA 11/2021 - 04/2015
3	Messenger RNA (mRNA)IBA 01/2021 - 12/2008
3	Transcription Factors (Transcription Factor)IBA 01/2018 - 07/2011
3	Membrane Proteins (Integral Membrane Proteins)IBA 03/2014 - 12/2008
3	Interleukin-2 (IL2)IBA 12/2013 - 02/2008
3	Interleukin-10 (Interleukin 10)IBA 12/2013 - 06/2006
2	AutoantigensIBA 01/2024 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2022
2	EpitopesIBA 01/2024 - 01/2023
2	LigandsIBA 09/2023 - 10/2014
2	AutoantibodiesIBA 01/2023 - 10/2021
2	DesminIBA 01/2022 - 07/2015
2	CollagenIBA 01/2022 - 01/2021
2	LipopolysaccharidesIBA 02/2021 - 01/2021
2	Therapeutic UsesIBA 02/2021 - 01/2021
2	Serum AlbuminIBA 11/2019 - 01/2017
2	Agammaglobulinaemia Tyrosine KinaseIBA 10/2019 - 01/2019
2	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 01/2019 - 01/2019
2	ibrutinibIBA 01/2019 - 01/2016
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2019 - 05/2017
2	Pyruvate KinaseIBA 01/2018 - 11/2017
2	Particulate MatterIBA 12/2017 - 01/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2014 - 09/2009
2	Sirolimus (Rapamycin)FDA Link 01/2013 - 01/2011
2	GastrinsIBA 02/2012 - 07/2011
2	Epidermal Growth Factor (EGF)IBA 02/2012 - 07/2011
2	Streptozocin (Streptozotocin)FDA Link 02/2012 - 07/2011
2	Insulin (Novolin)FDA Link 02/2012 - 07/2011
2	p80(NPM-ALK) proteinIBA 09/2011 - 04/2009
2	Transforming Growth Factor beta (TGF-beta)IBA 08/2008 - 06/2006
1	Glutathione (Reduced Glutathione)IBA 03/2024
1	PowdersIBA 03/2024
1	Immune Checkpoint InhibitorsIBA 01/2024
1	Cancer VaccinesIBA 01/2024
1	C-Type Lectins (C-Type Lectin)IBA 01/2024
1	AntigensIBA 01/2024
1	RicinIBA 01/2024
1	AlbuminsIBA 01/2024
1	Cysteine (L-Cysteine)FDA Link 01/2024
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2024
1	NAD (NADH)IBA 12/2023
1	A-factor (Streptomyces)IBA 11/2023
1	RNA (Ribonucleic Acid)IBA 10/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2023

Therapy/Procedure

10	Therapeutics 01/2024 - 09/2005
3	Renal Dialysis (Hemodialysis) 01/2021 - 07/2015
2	Immunotherapy 01/2024 - 01/2023
2	Drug Therapy (Chemotherapy) 01/2024 - 06/2017
2	Critical Care (Surgical Intensive Care) 11/2023 - 06/2023
2	Induction Chemotherapy 11/2022 - 07/2022
1	Early Ambulation 04/2024
1	Radiotherapy 01/2024
1	Biological Therapy 01/2024
1	Aftercare (After-Treatment) 01/2024
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2024